FDA flags Boston Scientific Imager II catheter risk as company removes product from market
Boston Scientific is removing all Imager II angiographic catheters from use after discovering that reduced stabilizing agents in catheter tips could increase degradation and detachment risk, while the medtech company simultaneously works through a separate global cyber disruption.